Continuing to spread its wings, India's Lupin now has a toehold in the Brazil market by buying Medquímica Indústria Farmacêutica, producer of branded, generic and over-the-counter drugs.
FiercePharmaAsia combs earnings calls by major drug companies for notable and quotable nuggets on emerging markets and Asia to track the latest sales trends and insight into business outlooks in markets as diverse as China, India and Japan to Southeast Asia.
Catalent has snapped up a Brazilian contract manufacturer, expanding its hold on the global softgel market by growing its presence in Latin America.
Providers of clinical trials tech have sought overseas partnerships as emerging and low-cost markets play larger roles in drug and device development. With more clinical trials outsourced overseas, according to a new study, China and the rest of Asia-Pacific territories, Latin America, the Middle East and Africa are expected to be the fastest-growing markets for eClinical technology.
DSM Pharmaceutical Products, the CMO wing of Royal DSM, has signed a deal to manufacture biologics for Brazil's Recepta Biopharma.
Quintiles is expanding its sales reach to Brazil, opening up an arm of its commercial solutions business to tap into that country's growing pharma market.
Ampio Pharmaceuticals is taking steps to get its premature-ejaculation drug on the market around the world.
Sponsors looking for clinical trial volunteers are better off heading south rather than east. Using systematic review and meta-analysis of data on people's willingness to participate in clinical
In a shot across Genzyme's damaged bow, Protalix and Pfizer are aligning with Brazil in a licensing deal for taliglucerase alfa, a treatment for Gaucher's disease. The Brazilian health minister says
GE Healthcare has opened its first factory in South America, in the town of Contagem, Brazil. With a planned investment of $50 million over a 10-year period, the company is committed to the